Graf Acquisition Corp. IV has entered into a merger agreement with NKGen Biotech, Inc., in which Merger Sub will merge with and into NKGen, with NKGen surviving as a wholly-owned subsidiary of Graf.
AI Assistant
NKGEN BIOTECH INC
2023
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.